Skip to content
GLP-1 Savers

Head-to-head · Value Score

NewSelf vs REMEVi

Two GLP-1 deals, scored on the same six factors. NewSelf lands a Value Score of 87, REMEVi a 89. Compare their advertised prices, billing terms, and what to check before paying.

By Grant Ashford, Founder & Pricing Editor

NewSelf

Grade A- · Great Deal

Advertised price

$134.99/mo at every dose

$134.99/mo at every dose (as low as $99.97 on a longer plan)

Save ~61% vs brand self-pay
Get this deal Full NewSelf review →
VS
★ Better value

REMEVi

Grade A · Great Deal

Advertised price

$143/mo month-to-month

$143/mo month-to-month ($96/mo on the 12-month plan, compounded)

Get this deal Full REMEVi review →

The verdict

Better value: REMEVi

REMEVi takes it on Value Score, 89 to 87 — at an advertised price of $143/mo month-to-month ($96/mo on the 12-month plan, compounded). Check the pricing terms before enrolling. NewSelf isn't out of it: Someone who expects to titrate high and wants the price to stay where it started.

Featured partner:CoreAge Rx, advertised prices with checkout conditions (Value Score 81).Read the review →

If neither program settles it, the Sprout Health review and the Bodybuilding Health+ review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealNewSelfREMEVi
Value Score87 (A-)89 (A)
Advertised price$134.99/mo at every dose (as low as $99.97 on a longer plan)$143/mo month-to-month ($96/mo on the 12-month plan, compounded)
Save vs brand self-pay~61%—
Semaglutide$134.99/mo at every dose (as low as $99.97 on a longer plan)$143/mo month-to-month ($96/mo on the 12-month plan, compounded)
Tirzepatide$224.99/mo at every dose (as low as $144.49 on a longer plan)$224/mo month-to-month ($168/mo on the 12-month plan, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
Coverage49 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

Lowest Real Price
NewSelf: 90. REMEVi: 82.
No Teaser-Rate Bait
NewSelf: 72. REMEVi: 90.
Nationwide Availability
NewSelf: 88. REMEVi: 96.
Both Molecules
NewSelf: 92. REMEVi: 98.
Easy Cancellation
NewSelf: 95. REMEVi: 95.
Reputation
NewSelf: 87. REMEVi: 87.

NewSelf

NewSelf sells compounded semaglutide with B12 or glycine at $134.99 a month and compounded tirzepatide with B6 and glycine at $224.99, both held flat across every dose, in 49 states.

Why it's a deal

  • The rate holds at every dose on both molecules — semaglutide across 0.25 mg to 2.5 mg, tirzepatide across 2.5 mg to 15 mg — so titrating up costs nothing extra
  • Both products are compounded with B12, B6 or glycine rather than sold as bare molecules, and the formulation is stated on the product card
  • HSA and FSA eligible, with the health screening, shipping and ongoing support inside the price
  • Names the 49 states it covers rather than implying nationwide reach

The fine print

  • The prominent $99.97 and $144.49 figures are plan floors, not the standing rates — those are $134.99 and $224.99
  • Not available in Mississippi or Louisiana
  • A "Tirzepatide Plus" tier at $399 a month sits above the standard product, so the flat-rate promise applies within a tier rather than across the range
  • Compounded only — no FDA-approved brand-name route

REMEVi

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

What's good

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly in one plan table rather than used as a teaser - semaglutide is $143 monthly, $125 on 3 months, $118 on 6 and $96 on 12
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

The fine print

  • The lowest figures need a full 12-month plan: semaglutide is $96 there against $143 month-to-month, and tirzepatide $168 against $224
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Get the NewSelf deal Get the REMEVi deal

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores NewSelf is ranked on the NewSelf alternatives ranking, and the same list for the other side is on alternatives to REMEVi.

More head-to-heads

The programs scoring closest to this pair, side by side.

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.